Evidence map›Paper›PMID 36575012›Full record

ReviewInternal medicine (Tokyo, Japan)2023

Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review.

Tsuyoshi Doman, Hiroaki Saito, Yukari Tanaka, Dai Hirasawa, Mareyuki Endo, Daichi Togo, Tomoki Matsuda

Open access · diamondAbstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tsuyoshi DomanDepartment of Gastroenterology, Sendai Kousei Hospital, Japan.
Hiroaki SaitoDepartment of Gastroenterology, Sendai Kousei Hospital, Japan.
Yukari TanakaDepartment of Gastroenterology, Sendai Kousei Hospital, Japan.
Dai HirasawaDepartment of Gastroenterology, Sendai Kousei Hospital, Japan.
Mareyuki EndoDepartment of Pathology, Sendai Kousei Hospital, Japan.
Daichi TogoDepartment of Gastroenterology, Sendai Kousei Hospital, Japan.
Tomoki MatsudaDepartment of Gastroenterology, Sendai Kousei Hospital, Japan.
Sendai Kousei Hospital · JPTohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 61-year-old man presented with a 7-day history of watery diarrhea and loss of appetite after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. Laboratory studies showed significant eosinophilia and an elevated IgE level (white cell count, 18.4×10

Indexed as

ColitisCOVID-19COVID-19 VaccinesEosinophiliaBNT162 VaccineHumansImmunoglobulin EMaleMiddle AgedRNA, MessengerBNT162 VaccineCOVID-19 VaccinesImmunoglobulin ERNA, MessengerCOVID-19diarrheahypereosinophiliamRNAvaccine

Identifiers

PMID36575012
PMCPMC10076129
OpenAlexW4313236380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.